Compare LKFT & TSLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | LKFT | TSLX |
|---|---|---|
| Founded | N/A | 2010 |
| Country | Belgium | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 1.8B |
| IPO Year | 2007 | 2011 |
| Metric | LKFT | TSLX |
|---|---|---|
| Price | $26.87 | $17.85 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 9 |
| Target Price | N/A | ★ $21.61 |
| AVG Volume (30 Days) | 221.6K | ★ 367.5K |
| Earning Date | N/A | 05-05-2026 |
| Dividend Yield | N/A | ★ 10.82% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.15 |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $1.20 |
| P/E Ratio | ★ N/A | $119.00 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $25.68 | $16.04 |
| 52 Week High | $30.91 | $24.76 |
| Indicator | LKFT | TSLX |
|---|---|---|
| Relative Strength Index (RSI) | 38.05 | 38.49 |
| Support Level | $25.68 | $17.20 |
| Resistance Level | $29.86 | $17.99 |
| Average True Range (ATR) | 0.55 | 0.33 |
| MACD | -0.19 | -0.17 |
| Stochastic Oscillator | 1.49 | 4.87 |
Lakefront Biotherapeutics NV a biopharmaceutical company committed to improving the lives of people with severe diseases. It focuses on delivering medicines with transformational impact for patients by accelerating life-changing science and innovation in areas of high unmet need. Its pipelines includes GLPG3667, GLPG5101, and GLPG5301.
Sixth Street Specialty Lending Inc is a specialty finance company focused on providing flexible, fully committed financing solutions to middle market companies located in the United States of America. The company partners with other companies across a variety of industries and provides creative solutions with complex business models that may have limited access to capital. The company seeks to generate current income in U.S.-domiciled middle-market companies through direct originations of senior secured loans and, to a lesser extent, originations of mezzanine and unsecured loans and investments in corporate bonds and equity securities.